Results 101 to 110 of about 39,875 (207)

Immune Checkpoint Inhibitor‐Associated Myocarditis With Myositis/Myasthenia Gravis Overlap Syndrome: Two Case Reports Highlighting Early Onset, Diagnostic Uncertainty, and Management Considerations

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
Custom illustration created by the author in collaboration with the Mayo Clinic Digital Media Department. ABSTRACT Immune checkpoint‐inhibitors (ICIs) have revolutionized and significantly improved cancer care through remarkable efficacy, but significant adverse effects have been observed.
Artur Schneider   +3 more
wiley   +1 more source

ASSOCIATION OF THROMBOLYSIS IN MYOCARDIAL INFARCTION (TIMI) RISK SCORE WITH EXTENT OF CORONARY ARTERY DISEASE IN PATIENTS WITH UNSTABLE ANGINA AND NSTEMI

open access: yesPakistan Armed Forces Medical Journal, 2020
Objective: To evaluate the correlation between thrombolytic in Myocardial Infarction risk score with the severity of coronary lesions found by coronary angiography during hospitalization in patients with non-ST elevation Acute coronary syndrome. Study
Saleha Abbas   +8 more
doaj   +1 more source

Aligning the planets: The role of nurses in the care of patients with non-ST elevation myocardial infarction. [PDF]

open access: yes, 2016
BACKGROUND: Studies have shown variation in care for patients with non-ST elevation myocardial infarction (NSTEMI), including in the roles of specialist and advanced practice nurses in diagnosis, treatment and coordination of care.
Cross   +13 more
core   +6 more sources

30-day in-hospital mortality after acute myocardial infarction in Tuscany (Italy): An observational study using hospital discharge data [PDF]

open access: yes, 2012
Background: Coronary heart disease is the leading cause of mortality in the world. One of the outcome indicators recently used to measure hospital performance is 30-day mortality after acute myocardial infarction (AMI). This indicator has proven to be
C. Seghieri   +3 more
core   +1 more source

European NSTEMI guidelines—return of clopidogrel? [PDF]

open access: yesEuropean Journal of Clinical Pharmacology, 2021
Lisa Dannenberg   +6 more
openaire   +3 more sources

Long-Term Prognosis in Young Patients with Acute Coronary Syndrome Treated with Percutaneous Coronary Intervention

open access: yesVascular Health and Risk Management, 2021
Oren Yagel,* Naseem Shadafny,* Ran Eliaz, Gil Dagan, David Leibowitz, Ilgar Tahiroglu, David Planer, Offer Amir, Gabby Elbaz Greener,* Ronny Alcalai* Department of Cardiology, Hadassah Medical Center, Jerusalem, Israel; Faculty of Medicine, Hebrew ...
Yagel O   +9 more
doaj  

MINOCA in Iceland. Acute coronary syndrome in patients with normal or nonobstructive coronary arteries [PDF]

open access: yes, 2018
To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked FilesInngangur: Hin hefðbundna meingerð í bráðu kransæðaheilkenni hefur lengst af ...
Ingibjörg Guðmundsdóttir   +5 more
core   +1 more source

Perspectives of ACC/AHA/SCAI myocardial revascularization 2022 guideline implementation in Kyrgyz Republic

open access: yesHeart Vessels and Transplantation, 2022
Aiperi Toktosunova   +1 more
doaj   +1 more source

Acute coronary syndrome (STEMI, NSTEMI and unstable angina pectoris) and risk factors, similarities and differences [PDF]

open access: yesScripta Medica, 2020
Introduction: Acute coronary syndrome (ACS) is one of the m ost common and most dramatic manifestations of ischaemic h eart disease and distinguishing of ACS from non-cardiac chest pain represents a diagnostic challenge.
Mihajlović Dalibor   +3 more
doaj  

Home - About - Disclaimer - Privacy